198 related articles for article (PubMed ID: 2866051)
1. The pathogenesis of Graves' disease.
Gossage AA; Munro DS
Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of Graves' disease and Hashimoto's thyroiditis.
Volpé R; Farid NR; Von Westarp C; Row VV
Clin Endocrinol (Oxf); 1974 Jul; 3(3):239-61. PubMed ID: 4601273
[No Abstract] [Full Text] [Related]
3. Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease.
Martin A; Goldsmith NK; Friedman EW; Schwartz AE; Davies TF; Roman SH
Autoimmunity; 1990; 6(4):269-81. PubMed ID: 1716476
[TBL] [Abstract][Full Text] [Related]
4. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
Nagataki S
Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of hyperthyroidism.
Chopra IJ; Solomon DH
Annu Rev Med; 1983; 34():267-81. PubMed ID: 6134495
[TBL] [Abstract][Full Text] [Related]
6. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune thyroid disease--a perspective.
Volpé R
Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
[TBL] [Abstract][Full Text] [Related]
8. Thyroid stimulating immunoglobulin in Graves' disease.
Luttrell BM; Hales IB
Aust N Z J Med; 1981 Jun; 11(3):293-8. PubMed ID: 6170289
[TBL] [Abstract][Full Text] [Related]
9. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
10. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
11. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
Baker JR; Saunders NB; Kaulfersch W; Burman KD
J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
[TBL] [Abstract][Full Text] [Related]
13. [Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].
Allannic H; Genetet N; Edan G; Merdrignac G; Simon M; Genetet B
Pathol Biol (Paris); 1987 Dec; 35(10):1333-8. PubMed ID: 2449649
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
[No Abstract] [Full Text] [Related]
15. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
Selenkow HA; Wyman P; Allweiss P
Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
[TBL] [Abstract][Full Text] [Related]
16. [Significance of circulating anti-thyroid stimulating hormone (TSH) receptor antibodies in patients with autoimmune thyroid diseases--thyroid stimulation blocking antibody in patients with Graves' disease].
Fujihira T
J UOEH; 1989 Dec; 11(4):393-401. PubMed ID: 2575267
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
Bech K
Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
[No Abstract] [Full Text] [Related]
18. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
19. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
